- Published on
Pathology - Obstructive nephropathy
Definition: Renal impairment resulting from blockage in the urinary tract. Epidemiology: Primarily observed in youngsters (attributable to congenital urinary tract defects) and elderly males (resulting from prostatic hyperplasia). Aetiology • Obstruction can manifest at any location within the urinary system Common etiologies encompass urinary calculi, pelviureteric junction obstruction, prostatic hyperplasia, urothelial tumors, and ureteral compression by abdominal or pelvic masses.
Pathogenesis • Renal injury is mostly considered a pressure-related condition, although concurrent infection may also play a role.
Presentation • The clinical manifestations are varied. contingent upon the severity of the condition and its laterality. • Patients may be asymptomatic or exhibit hypertension, polyuria, or renal failure.
Macroscopy • The kidney is diminutive and atrophied, exhibiting hydronephrosis, widespread calyceal dilatation, papillary blunting, and cortical thinning.
Histopathology • The renal parenchyma exhibits characteristics of chronic pyelonephritis, including significant tubulointerstitial fibrosis and tubular atrophy. • Atrophic tubules are frequently dilated and contain proteinaceous material, a phenomenon referred to as 'thyroidization.' • The collecting system has significant chronic inflammation characterized by lymphoid clusters and follicles. • Remaining glomeruli may display hypertrophy and subsequent glomerulosclerosis.
The phrase ‘chronic pyelonephritis’ denotes a set of clinical characteristics that are not exclusive to obstructive nephropathy and may also occur in other conditions, such as reflux nephropathy. Distinction is typically achievable based on the clinical presentation and scarring pattern.
Prognosis: Patients with substantial bilateral illness are at risk of experiencing increasing renal impairment.
Definition: Renal impairment resulting from blockage in the urinary tract. Epidemiology: Primarily observed in youngsters (attributable to congenital urinary tract defects) and elderly males (resulting from prostatic hyperplasia). Aetiology • Obstruction can manifest at any location within the urinary system Common etiologies encompass urinary calculi, pelviureteric junction obstruction, prostatic hyperplasia, urothelial tumors, and ureteral compression by abdominal or pelvic masses.
Pathogenesis • Renal injury is mostly considered a pressure-related condition, although concurrent infection may also play a role.
Presentation • The clinical manifestations are varied. contingent upon the severity of the condition and its laterality. • Patients may be asymptomatic or exhibit hypertension, polyuria, or renal failure.
Macroscopy • The kidney is diminutive and atrophied, exhibiting hydronephrosis, widespread calyceal dilatation, papillary blunting, and cortical thinning.
Histopathology • The renal parenchyma exhibits characteristics of chronic pyelonephritis, including significant tubulointerstitial fibrosis and tubular atrophy. • Atrophic tubules are frequently dilated and contain proteinaceous material, a phenomenon referred to as 'thyroidization.' • The collecting system has significant chronic inflammation characterized by lymphoid clusters and follicles. • Remaining glomeruli may display hypertrophy and subsequent glomerulosclerosis.
The phrase ‘chronic pyelonephritis’ denotes a set of clinical characteristics that are not exclusive to obstructive nephropathy and may also occur in other conditions, such as reflux nephropathy. Distinction is typically achievable based on the clinical presentation and scarring pattern.
Prognosis: Patients with substantial bilateral illness are at risk of experiencing increasing renal impairment.
- Published on
Pathology - Focal segmental glomerulosclerosis
It is a primary glomerulopathy defined histologically by sclerosis affecting some, but not all, glomeruli (focal) and engaging just a section of the glomerular tuft (segmental). 2 Segmental glomerulosclerosis is simply an indicator of glomerular damage; it can occur in several circumstances and is not exclusive to FSGS. Meticulous elimination of alternative recognized etiologies of segmental glomerulosclerosis is necessary before to diagnosing FSGS, as this designation indicates a condition anticipated to swiftly advance to end-stage renal failure.
Epidemiology: Rare occurrence.
Aetiology • The cause remains unidentified, however the recurrence of the condition in transplanted kidneys implies the presence of a circulating factor. • An uncommon hereditary variant of the disease is also present. Pathogenesis Recent investigations indicate that the podocyte is the principal source of harm. Podocyte damage results in significant proteinuria, subsequently leading to glomerular scarring and quickly progressive renal failure.
Presentation of nephrotic syndrome.
Light microscopy • Affected glomeruli exhibit collapse of a portion of the tuft, replaced by sclerosis. • The sclerotic segment frequently demonstrates adhesion to the adjacent epithelial cells of Bowman’s space. •
Glomerulosclerosis is typically associated with tubulointerstitial fibrosis surrounding the affected glomerulus. Immunofluorescence • Non-specific trapping of IgM and C3 may be observed in regions of sclerosis. Electron microscopy reveals podocyte foot process effacement. • Immune deposits are absent.
Prognosis: Nearly all instances of FSGS are progressive, with the majority of patients attaining end-stage renal failure within a few years post-diagnosis.
It is a primary glomerulopathy defined histologically by sclerosis affecting some, but not all, glomeruli (focal) and engaging just a section of the glomerular tuft (segmental). 2 Segmental glomerulosclerosis is simply an indicator of glomerular damage; it can occur in several circumstances and is not exclusive to FSGS. Meticulous elimination of alternative recognized etiologies of segmental glomerulosclerosis is necessary before to diagnosing FSGS, as this designation indicates a condition anticipated to swiftly advance to end-stage renal failure.
Epidemiology: Rare occurrence.
Aetiology • The cause remains unidentified, however the recurrence of the condition in transplanted kidneys implies the presence of a circulating factor. • An uncommon hereditary variant of the disease is also present. Pathogenesis Recent investigations indicate that the podocyte is the principal source of harm. Podocyte damage results in significant proteinuria, subsequently leading to glomerular scarring and quickly progressive renal failure.
Presentation of nephrotic syndrome.
Light microscopy • Affected glomeruli exhibit collapse of a portion of the tuft, replaced by sclerosis. • The sclerotic segment frequently demonstrates adhesion to the adjacent epithelial cells of Bowman’s space. •
Glomerulosclerosis is typically associated with tubulointerstitial fibrosis surrounding the affected glomerulus. Immunofluorescence • Non-specific trapping of IgM and C3 may be observed in regions of sclerosis. Electron microscopy reveals podocyte foot process effacement. • Immune deposits are absent.
Prognosis: Nearly all instances of FSGS are progressive, with the majority of patients attaining end-stage renal failure within a few years post-diagnosis.
- Published on
Surgery -Fluid Optimization
Identifying Patients in Need of Fluid Optimization
Preoperative fluid resuscitation can benefit any patient, although certain groups are more likely to require it. Consider less obvious situations of fluid depletion. More patients could benefit from fluid optimization than currently receive it. • Sudden vomiting or diarrhea, maybe due to intestinal blockage, biliary colic, or gastroenteritis.
• Patients who have been immobile or debilitated for a period of time, resulting in reduced fluid intake, such as pancreatitis, chest infections, acute-on-chronic vascular insufficiency, or prolonged sepsis with pyrexia.
• Elderly patients with reduced renal reserve, making fluid balance control less effective.
• Drugs that inhibit renal reactions to fluid fluctuations, such as diuretics. Patients with low body weight and smaller total body fluid volume experience larger effects from similar reductions.
• Children are particularly vulnerable to fluid deprivation and may not exhibit visible physical symptoms. Fluids utilized for optimization. Fluid optimization relies on employing the appropriate volumes and rates. In most cases, isotonic crystalloids are the preferred fluid for balancing out imbalances
• The most often utilized fluid is 0.9% isotonic saline ('normal'). When renal function is adequate, isotonic saline minimizes rapid fluid changes during rehydration and excretes excess sodium (Na+) through the kidneys. Add potassium (K+) only if d K+ is present or probable (e.g., prolonged vomiting, pancreatic or small bowel fistula). Glucose (4%), Hartmann's solution, and Ringer's lactate solution are examples of crystalloids. While Ringer's lactate solution has a fluid composition similar to serum, its theoretical benefits are restricted in practice. Hypertonic (1.8%) and hypotonic (0.45%) saline should be used with caution as they might produce fluid changes in and out of cells, potentially causing harm, especially to neurons. Patients with substantial Na+ balance disorders may require non-isotonic fluid adjustment in HDU. How to Give the Fluids Before administering liquids, it is necessary to determine the volume of depletion. Estimates of losses due to vomiting or diarrhea are typically erroneous. Useful calculations include the following:
• Use a recent correct body weight from normal health for admission, as acute weight loss is primarily water-based.
• If a recent haematocrit from normal health is available, admission haematocrit can be used to determine the degree of haemoconcentration caused by fluid loss. The approximate calculation is: fluid depletion (L) = (PCV1 - PCV2)/PCV1) times 0.7 × weight (kg). (PCV1 = normal haematocrit, PCV2 = current haematocrit.)
• Dehydration, renal disease, GI bleeds, and acute proteolysis raise serum urea more than serum Cr. • Signs of ECF depletion (lax skin tone, reduced sweating, dry mucosae) can be misleading and influenced by age and underlying diseases, such as pyrexia and tachypnea. • Signs of intravascular volume depletion, such as hypotension and tachycardia, can be inaccurate and often occur after losing 10-15% of body water. Once the volume of fluid required has been determined, it can be administered. There are several broad guidelines for administering fluid resuscitation. • Young, fit patients with normal renal and cardiac function can receive up to 15% of body fluid volume via fast infusion.
A common treatment involves infusing 1000mL of 0.9% saline over 2 hours, followed by additional 1000mL infusions over 4 hours until corrected. Elderly patients and those with renal or cardiac impairment should have slower infusions to avoid severe intravascular volume overload. A common treatment involves administering 1000mL of 0.9% saline over 4 hours, followed by a 500mL infusion of 0.9% saline over 3-4 hours. Vital signs, including chest auscultation, should be monitored regularly. Complex patients or those who do not react to initial treatment should be discussed with elders and/or other specialists as they may require monitoring in critical care. Monitoring fluid optimization.
Fluid optimization progress can be assessed using the following methods: • Optimized skin turgor and mucosal hydration are unreliable guides due to gradual changes. • Measuring urine output every hour can provide insight into renal blood flow, which in turn affects intravascular fluid volume and cardiac output. It is a reliable indicator of sufficient blood volume replenishment. Although urine flow is adequate, it is not a reliable measure of total body water due to potential intra- and extracellular depletion. A usual minimum is 0.5mL/kg/h. • Monitoring serum urea can offer an approximate guideline if renal function is adequate and there is no acute GI bleeding or proteolysis. In emergency situations, fast fluid infusions may be necessary for patients requiring surgery and fluid optimization before anesthesia. This can be monitored on HDU.
Identifying Patients in Need of Fluid Optimization
Preoperative fluid resuscitation can benefit any patient, although certain groups are more likely to require it. Consider less obvious situations of fluid depletion. More patients could benefit from fluid optimization than currently receive it. • Sudden vomiting or diarrhea, maybe due to intestinal blockage, biliary colic, or gastroenteritis.
• Patients who have been immobile or debilitated for a period of time, resulting in reduced fluid intake, such as pancreatitis, chest infections, acute-on-chronic vascular insufficiency, or prolonged sepsis with pyrexia.
• Elderly patients with reduced renal reserve, making fluid balance control less effective.
• Drugs that inhibit renal reactions to fluid fluctuations, such as diuretics. Patients with low body weight and smaller total body fluid volume experience larger effects from similar reductions.
• Children are particularly vulnerable to fluid deprivation and may not exhibit visible physical symptoms. Fluids utilized for optimization. Fluid optimization relies on employing the appropriate volumes and rates. In most cases, isotonic crystalloids are the preferred fluid for balancing out imbalances
• The most often utilized fluid is 0.9% isotonic saline ('normal'). When renal function is adequate, isotonic saline minimizes rapid fluid changes during rehydration and excretes excess sodium (Na+) through the kidneys. Add potassium (K+) only if d K+ is present or probable (e.g., prolonged vomiting, pancreatic or small bowel fistula). Glucose (4%), Hartmann's solution, and Ringer's lactate solution are examples of crystalloids. While Ringer's lactate solution has a fluid composition similar to serum, its theoretical benefits are restricted in practice. Hypertonic (1.8%) and hypotonic (0.45%) saline should be used with caution as they might produce fluid changes in and out of cells, potentially causing harm, especially to neurons. Patients with substantial Na+ balance disorders may require non-isotonic fluid adjustment in HDU. How to Give the Fluids Before administering liquids, it is necessary to determine the volume of depletion. Estimates of losses due to vomiting or diarrhea are typically erroneous. Useful calculations include the following:
• Use a recent correct body weight from normal health for admission, as acute weight loss is primarily water-based.
• If a recent haematocrit from normal health is available, admission haematocrit can be used to determine the degree of haemoconcentration caused by fluid loss. The approximate calculation is: fluid depletion (L) = (PCV1 - PCV2)/PCV1) times 0.7 × weight (kg). (PCV1 = normal haematocrit, PCV2 = current haematocrit.)
• Dehydration, renal disease, GI bleeds, and acute proteolysis raise serum urea more than serum Cr. • Signs of ECF depletion (lax skin tone, reduced sweating, dry mucosae) can be misleading and influenced by age and underlying diseases, such as pyrexia and tachypnea. • Signs of intravascular volume depletion, such as hypotension and tachycardia, can be inaccurate and often occur after losing 10-15% of body water. Once the volume of fluid required has been determined, it can be administered. There are several broad guidelines for administering fluid resuscitation. • Young, fit patients with normal renal and cardiac function can receive up to 15% of body fluid volume via fast infusion.
A common treatment involves infusing 1000mL of 0.9% saline over 2 hours, followed by additional 1000mL infusions over 4 hours until corrected. Elderly patients and those with renal or cardiac impairment should have slower infusions to avoid severe intravascular volume overload. A common treatment involves administering 1000mL of 0.9% saline over 4 hours, followed by a 500mL infusion of 0.9% saline over 3-4 hours. Vital signs, including chest auscultation, should be monitored regularly. Complex patients or those who do not react to initial treatment should be discussed with elders and/or other specialists as they may require monitoring in critical care. Monitoring fluid optimization.
Fluid optimization progress can be assessed using the following methods: • Optimized skin turgor and mucosal hydration are unreliable guides due to gradual changes. • Measuring urine output every hour can provide insight into renal blood flow, which in turn affects intravascular fluid volume and cardiac output. It is a reliable indicator of sufficient blood volume replenishment. Although urine flow is adequate, it is not a reliable measure of total body water due to potential intra- and extracellular depletion. A usual minimum is 0.5mL/kg/h. • Monitoring serum urea can offer an approximate guideline if renal function is adequate and there is no acute GI bleeding or proteolysis. In emergency situations, fast fluid infusions may be necessary for patients requiring surgery and fluid optimization before anesthesia. This can be monitored on HDU.
- Published on
Pathology - diabetic nephropathy
Definition: Chronic kidney disease caused by diabetes mellitus.
Epidemiology • A leading cause of chronic renal disease.
Aetiology • Diabetes. • Only 30-40% of diabetics develop nephropathy, suggesting that other factors play a role.
Pathogenesis • High glucose levels harm endothelial cells in the glomeruli, resulting in glomerulosclerosis and nephron loss.
Presentation • A patient with diabetes mellitus develops proteinuria. • Microalbuminuria often precedes overt proteinuria, which can lead to nephrotic syndrome. • Hypertension is always present.
Histopathology • Glomerulosclerosis, a diffuse increase in the mesangial matrix, can lead to the formation of Kimmelsteil-Wilson nodules. • Thicker glomerular basement membranes. • Hyalinization of the afferent and efferent arterioles. • Tubulointerstitial fibrosis is proportional to glomerular injury. 2 A kidney biopsy is not essential to confirm a diagnosis of diabetic nephropathy if the clinical presentation is typical. Biopsies are often reserved for unusual cases where alternate diagnoses may be possible. immune fluorescence • IgG deposition in glomerular and tubular basement membranes can be observed. Electron microscopy • Thickened glomerular basement membrane and expanded mesangial matrix are observed. • There are no immunological complexes present.
Prognosis: Gradual decline in renal function. • Patients with severe hypertension and significant proteinuria fare poorly. • Proper blood pressure management is crucial for reducing disease progression.
Definition: Chronic kidney disease caused by diabetes mellitus.
Epidemiology • A leading cause of chronic renal disease.
Aetiology • Diabetes. • Only 30-40% of diabetics develop nephropathy, suggesting that other factors play a role.
Pathogenesis • High glucose levels harm endothelial cells in the glomeruli, resulting in glomerulosclerosis and nephron loss.
Presentation • A patient with diabetes mellitus develops proteinuria. • Microalbuminuria often precedes overt proteinuria, which can lead to nephrotic syndrome. • Hypertension is always present.
Histopathology • Glomerulosclerosis, a diffuse increase in the mesangial matrix, can lead to the formation of Kimmelsteil-Wilson nodules. • Thicker glomerular basement membranes. • Hyalinization of the afferent and efferent arterioles. • Tubulointerstitial fibrosis is proportional to glomerular injury. 2 A kidney biopsy is not essential to confirm a diagnosis of diabetic nephropathy if the clinical presentation is typical. Biopsies are often reserved for unusual cases where alternate diagnoses may be possible. immune fluorescence • IgG deposition in glomerular and tubular basement membranes can be observed. Electron microscopy • Thickened glomerular basement membrane and expanded mesangial matrix are observed. • There are no immunological complexes present.
Prognosis: Gradual decline in renal function. • Patients with severe hypertension and significant proteinuria fare poorly. • Proper blood pressure management is crucial for reducing disease progression.
- Published on
Pathology - Hypertensive Nephropathy
Definition: Chronic renal disease associated with hypertension. Epidemiology: • Common causes of chronic kidney disease.
Aetiology • Hypertension
Pathogenesis • Two pathophysiological explanations have been proposed and may not be mutually exclusive. • Arteriole constriction leads to glomerular ischemia and scarring, while glomerular hypertension produces glomerular hyperfiltration and eventual glomerulosclerosis. Presentation: Renal failure and proteinuria in a long-standing hypertensive with no additional causes of renal illness. • Additional indicators of hypertension, such as left ventricular hypertrophy, may also be present.
Macroscopy: • Both kidneys are shrunken, with finely granular cortical surfaces. Histopathology • Afferent arterioles have hyaline deposits. • Medial hypertrophy and intimal thickening are seen in interlobular and larger arteries. • Glomeruli may show wrinkling and shrinkage followed by scarring of the whole tuft or enlargement of the tuft followed by segmental scarring. • These pathological features are referred to as nephrosclerosis, which simply means hardening of the kidney.
The appearance of nephrosclerosis may not necessarily indicate hypertensive nephropathy, as similar alterations might occur with aging or diabetes. However, a kidney biopsy can confirm a diagnosis of hypertensive nephropathy if the clinical presentation matches.
Prognosis: • Chronic kidney disease tends to progress. • Aggressive blood pressure control can reduce the deterioration in renal function.
Definition: Chronic renal disease associated with hypertension. Epidemiology: • Common causes of chronic kidney disease.
Aetiology • Hypertension
Pathogenesis • Two pathophysiological explanations have been proposed and may not be mutually exclusive. • Arteriole constriction leads to glomerular ischemia and scarring, while glomerular hypertension produces glomerular hyperfiltration and eventual glomerulosclerosis. Presentation: Renal failure and proteinuria in a long-standing hypertensive with no additional causes of renal illness. • Additional indicators of hypertension, such as left ventricular hypertrophy, may also be present.
Macroscopy: • Both kidneys are shrunken, with finely granular cortical surfaces. Histopathology • Afferent arterioles have hyaline deposits. • Medial hypertrophy and intimal thickening are seen in interlobular and larger arteries. • Glomeruli may show wrinkling and shrinkage followed by scarring of the whole tuft or enlargement of the tuft followed by segmental scarring. • These pathological features are referred to as nephrosclerosis, which simply means hardening of the kidney.
The appearance of nephrosclerosis may not necessarily indicate hypertensive nephropathy, as similar alterations might occur with aging or diabetes. However, a kidney biopsy can confirm a diagnosis of hypertensive nephropathy if the clinical presentation matches.
Prognosis: • Chronic kidney disease tends to progress. • Aggressive blood pressure control can reduce the deterioration in renal function.
- Published on
Pathology - Acute renal failure
Definition: Significant deterioration in renal function over hours or days.
Epidemiology • Common. • This condition is typically a complication of a pre-existing sickness that disrupts circulation.
Aetiology • Hypoperfusion, such as hypovolaemia or sepsis, occurs prior to renal function.
• Renal ('intrinsic'): acute tubular injury, drug-induced interstitial nephritis, anti-glomerular basement membrane disease, small vessel vasculitis, hemolytic uraemic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP) and severe hypertension.
• Post-renal: bilateral obstruction (or obstruction of a single kidney). 2 The most prevalent causes are hypoperfusion and acute tubular damage.
Pathogenesis: • Kidney disease causes sudden decline in function.
Presentation: • Oliguria (passing little amounts of urine) is the most common symptom, but some cases may show no symptoms. • Severe cases result in pulmonary edema, encephalopathy, and pericarditis.
Biochemistry: Serum urea and creatinine are key indicators. • Hyperkalemia and metabolic acidosis are also prevalent. Severe hyperkalemia is pro-arrhythmic and can cause cardiac arrest, requiring rapid treatment. Prognosis • Pre-renal and post-renal acute renal failure (ARF) can be reversible if promptly addressed by restoring circulation volume or alleviating obstruction. • Intrinsic types of ARF typically necessitate dialysis while the underlying etiology is managed and renal function recuperates.
Definition: Significant deterioration in renal function over hours or days.
Epidemiology • Common. • This condition is typically a complication of a pre-existing sickness that disrupts circulation.
Aetiology • Hypoperfusion, such as hypovolaemia or sepsis, occurs prior to renal function.
• Renal ('intrinsic'): acute tubular injury, drug-induced interstitial nephritis, anti-glomerular basement membrane disease, small vessel vasculitis, hemolytic uraemic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP) and severe hypertension.
• Post-renal: bilateral obstruction (or obstruction of a single kidney). 2 The most prevalent causes are hypoperfusion and acute tubular damage.
Pathogenesis: • Kidney disease causes sudden decline in function.
Presentation: • Oliguria (passing little amounts of urine) is the most common symptom, but some cases may show no symptoms. • Severe cases result in pulmonary edema, encephalopathy, and pericarditis.
Biochemistry: Serum urea and creatinine are key indicators. • Hyperkalemia and metabolic acidosis are also prevalent. Severe hyperkalemia is pro-arrhythmic and can cause cardiac arrest, requiring rapid treatment. Prognosis • Pre-renal and post-renal acute renal failure (ARF) can be reversible if promptly addressed by restoring circulation volume or alleviating obstruction. • Intrinsic types of ARF typically necessitate dialysis while the underlying etiology is managed and renal function recuperates.
- Published on
Pathology -Chronic renal disease.
Definition: A progressive and irreversible loss in renal function, classified into five phases based on estimated glomerular filtration rate (eGFR) (Table 9.1).
Epidemiology: Diabetes and kidney vascular disease contribute to the high prevalence of this condition. Aetiology • Diabetic and hypertensive nephropathy are the leading causes. • Other causes include reflex nephropathy, obstructive nephropathy, IgA nephropathy (IgAN), focal segmental glomerulosclerosis (FSGS), membranous nephropathy, systemic lupus erythematosus (SLE), myeloma, amyloidosis, medications, gout, and adult polycystic kidney disease (APKD).
Pathogenesis • A decrease in nephron mass below a certain level can lead to progressive renal damage, regardless of the underlying disease. • The sequence of events causing progressive renal damage is thought to be glomerular hyperfiltration, hypertension, injury, glomerulosclerosis, and tubulointerstitial fibrosis. • TGF-B plays a vital role in promoting renal scarring. Early illness is asymptomatic and can only be detected by measuring eGFR in at-risk patients, such as diabetics or hypertensives. • As patients advance, they become weary and have bone pain.
• End-stage renal failure patients with fluid overload and metabolic abnormalities may require prompt renal replacement therapy. Biochemistry • Urea and creatinine levels are elevated due to poor waste product excretion. • Reduced Calcium due to a shortage of active calcitriol. • increase Phosphate due to inadequate phosphate excretion. • Secondary hyperparathyroidism caused by low calcium levels. •Reduced haemoglobin levels due to decreased erythropoietin production.Loss of acid-base and sodium/potassium equilibrium happens later in chronic renal disease.
Complications • High risk of cardiovascular disease due to hypertension, vascular calcification, and hyperlipidemia. • Deranged calcium and phosphate metabolism causes renal bone disease, a complicated combination of hyperparathyroidism, osteomalacia, and osteoporosis.
Definition: A progressive and irreversible loss in renal function, classified into five phases based on estimated glomerular filtration rate (eGFR) (Table 9.1).
Epidemiology: Diabetes and kidney vascular disease contribute to the high prevalence of this condition. Aetiology • Diabetic and hypertensive nephropathy are the leading causes. • Other causes include reflex nephropathy, obstructive nephropathy, IgA nephropathy (IgAN), focal segmental glomerulosclerosis (FSGS), membranous nephropathy, systemic lupus erythematosus (SLE), myeloma, amyloidosis, medications, gout, and adult polycystic kidney disease (APKD).
Pathogenesis • A decrease in nephron mass below a certain level can lead to progressive renal damage, regardless of the underlying disease. • The sequence of events causing progressive renal damage is thought to be glomerular hyperfiltration, hypertension, injury, glomerulosclerosis, and tubulointerstitial fibrosis. • TGF-B plays a vital role in promoting renal scarring. Early illness is asymptomatic and can only be detected by measuring eGFR in at-risk patients, such as diabetics or hypertensives. • As patients advance, they become weary and have bone pain.
• End-stage renal failure patients with fluid overload and metabolic abnormalities may require prompt renal replacement therapy. Biochemistry • Urea and creatinine levels are elevated due to poor waste product excretion. • Reduced Calcium due to a shortage of active calcitriol. • increase Phosphate due to inadequate phosphate excretion. • Secondary hyperparathyroidism caused by low calcium levels. •Reduced haemoglobin levels due to decreased erythropoietin production.Loss of acid-base and sodium/potassium equilibrium happens later in chronic renal disease.
Complications • High risk of cardiovascular disease due to hypertension, vascular calcification, and hyperlipidemia. • Deranged calcium and phosphate metabolism causes renal bone disease, a complicated combination of hyperparathyroidism, osteomalacia, and osteoporosis.
- Published on
Pathology - Acinar Cell Carcinoma
Definition: A malignant epithelial tumor in the pancreas that produces enzymes.
Epidemiology • This rare tumor accounts for around 1% of all pancreatic tumors. • The majority occur in older persons.
Aetiology: unknown. Carcinogenesis has been linked to abnormalities in the APC/B-catenin pathway.
• Genetic alterations common in ductal adenocarcinoma are missing.
Presentation: General symptoms include stomach pain, weight loss, nausea, and diarrhea. • Approximately 10% of individuals experience polyarthralgia and multifocal fat necrosis due to lipase secretion.
Macroscopy reveals a well-defined soft tan tumor in the pancreas. • An extension outside the pancreas may be present. Histopathology • Neoplastic epithelial cells form in sheets, trabeculae, and acini. • Some cells have eosinophilic finely granular cytoplasm.
• Immunoreactivity for lipase, trypsin, and chymotrypsin is positive.
Prognosis: Aggressive malignant tumors. • The median survival time following diagnosis is 18 months, with a 5-year survival rate of
Definition: A malignant epithelial tumor in the pancreas that produces enzymes.
Epidemiology • This rare tumor accounts for around 1% of all pancreatic tumors. • The majority occur in older persons.
Aetiology: unknown. Carcinogenesis has been linked to abnormalities in the APC/B-catenin pathway.
• Genetic alterations common in ductal adenocarcinoma are missing.
Presentation: General symptoms include stomach pain, weight loss, nausea, and diarrhea. • Approximately 10% of individuals experience polyarthralgia and multifocal fat necrosis due to lipase secretion.
Macroscopy reveals a well-defined soft tan tumor in the pancreas. • An extension outside the pancreas may be present. Histopathology • Neoplastic epithelial cells form in sheets, trabeculae, and acini. • Some cells have eosinophilic finely granular cytoplasm.
• Immunoreactivity for lipase, trypsin, and chymotrypsin is positive.
Prognosis: Aggressive malignant tumors. • The median survival time following diagnosis is 18 months, with a 5-year survival rate of
- Published on
Pathology – Acute Pancreatitis
Acute pancreatitis is defined as acute inflammation of the pancreas and surrounding tissues.
Epidemiology • Uncommon.
Aetiology • Gallstones and alcohol are responsible for the majority of instances. • Other reasons include abdominal trauma, endoscopic retrograde cholangiopancreatography (ERCP), medications, hypercalcemia, pancreatic divisum, and viral infection. • Most cases are idiopathic.
Pathogenesis • Pancreatic injury triggers the release of digestive enzymes, resulting in necrosis of pancreatic and peripancreatic tissues. • Exudation of plasma into the retroperitoneal area causes hypovolemia and cardiovascular instability. • Paralytic ileus can also be caused by severe inflammation near the gut.
Presentation: Sudden onset of severe upper abdominal discomfort spreading to the back, accompanied by nausea, vomiting, and fever. Hypotension may occur, leading to shock.
Biochemistry: A significant increase in serum amylase can indicate acute pancreatitis in the appropriate clinical situation.
Macroscopy reveals an enlarged and squishy pancreas. • Peripancreatic tissues show white flecks of fat necrosis. • Severe instances result in bleeding into the necrotic pancreas.
Histopathology reveals acute inflammation, oedema, and localized necrosis of the pancreas. • There is fat necrosis around the peripancreatic tissue. • Severe cases have extensive necrosis and bleeding within the gland.
Prognosis: • Most instances are moderate and treatable with supportive measures. • Severe cases may require organ support in an intensive care unit. • Infection of necrotic pancreatic tissue can result in disseminated intravascular coagulation and multiple organ failure. • Pancreatic pseudocysts, an accumulation of fluid within the pancreas, are a typical late consequence.
Acute pancreatitis is defined as acute inflammation of the pancreas and surrounding tissues.
Epidemiology • Uncommon.
Aetiology • Gallstones and alcohol are responsible for the majority of instances. • Other reasons include abdominal trauma, endoscopic retrograde cholangiopancreatography (ERCP), medications, hypercalcemia, pancreatic divisum, and viral infection. • Most cases are idiopathic.
Pathogenesis • Pancreatic injury triggers the release of digestive enzymes, resulting in necrosis of pancreatic and peripancreatic tissues. • Exudation of plasma into the retroperitoneal area causes hypovolemia and cardiovascular instability. • Paralytic ileus can also be caused by severe inflammation near the gut.
Presentation: Sudden onset of severe upper abdominal discomfort spreading to the back, accompanied by nausea, vomiting, and fever. Hypotension may occur, leading to shock.
Biochemistry: A significant increase in serum amylase can indicate acute pancreatitis in the appropriate clinical situation.
Macroscopy reveals an enlarged and squishy pancreas. • Peripancreatic tissues show white flecks of fat necrosis. • Severe instances result in bleeding into the necrotic pancreas.
Histopathology reveals acute inflammation, oedema, and localized necrosis of the pancreas. • There is fat necrosis around the peripancreatic tissue. • Severe cases have extensive necrosis and bleeding within the gland.
Prognosis: • Most instances are moderate and treatable with supportive measures. • Severe cases may require organ support in an intensive care unit. • Infection of necrotic pancreatic tissue can result in disseminated intravascular coagulation and multiple organ failure. • Pancreatic pseudocysts, an accumulation of fluid within the pancreas, are a typical late consequence.
- Published on
Pathology - Pancreatic malformations
Ectopic pancreas is a common developmental defect that occurs when pancreatic tissue is placed outside of its normal position. • The duodenum is the most common location, but it can also be found in the jejunum, ileum, and Meckel's diverticulum • While most cases are unintentional, some patients may experience symptoms such as bleeding or blockage.
Pancreas Divisum • A common developmental abnormality in which the dorsal and ventral pancreatic buds fail to merge. • The Santorini duct becomes the pancreas' major ductal system. This duct drains into the duodenum via the minor papilla, leading to pancreatic secretory stasis and susceptibility to pancreatitis. It is typically asymptomatic and detected during imaging, however some patients may develop pancreatitis later in life.
Annular pancreas • A rare developmental defect occurs when the dorsal and ventral pancreatic buds unite around the duodenum. • The ring of pancreas can cause obstruction to the duodenum. • Patients often arrive around 1 year of age with vomiting and abdominal distention after meals.
Ectopic pancreas is a common developmental defect that occurs when pancreatic tissue is placed outside of its normal position. • The duodenum is the most common location, but it can also be found in the jejunum, ileum, and Meckel's diverticulum • While most cases are unintentional, some patients may experience symptoms such as bleeding or blockage.
Pancreas Divisum • A common developmental abnormality in which the dorsal and ventral pancreatic buds fail to merge. • The Santorini duct becomes the pancreas' major ductal system. This duct drains into the duodenum via the minor papilla, leading to pancreatic secretory stasis and susceptibility to pancreatitis. It is typically asymptomatic and detected during imaging, however some patients may develop pancreatitis later in life.
Annular pancreas • A rare developmental defect occurs when the dorsal and ventral pancreatic buds unite around the duodenum. • The ring of pancreas can cause obstruction to the duodenum. • Patients often arrive around 1 year of age with vomiting and abdominal distention after meals.
